Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
September-2019 Volume 18 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2019 Volume 18 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Tanshinone IIA inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cells via p53‑cyclin B1/CDC2

  • Authors:
    • Bin Liu
    • Lixia Liu
    • Aimin Zang
    • Zizheng Song
    • Hua Yang
    • Zhiyu Wang
    • Yanhong Shang
    • Tao Ma
    • Yonggang Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Oncology, Affiliated Hospital of Hebei University, Baoding, Hebei 071000, P.R. China, Department of Functions Branch, Affiliated Hospital of Hebei University, Baoding, Hebei 071000, P.R. China, Department of Surgery, Baoding No.1 Central Hospital, Baoding, Hebei 071000, P.R. China, Department of Surgery, Affiliated Hospital of Hebei University, Baoding, Hebei 071000, P.R. China
  • Pages: 3317-3322
    |
    Published online on: July 24, 2019
       https://doi.org/10.3892/ol.2019.10658
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Tanshinone IIA exhibits natural antioxidative and antineoplastic activity. However, to the best of our knowledge, the effects of tanshinone IIA on human nasopharyngeal carcinoma cells remains unknown. The present study aimed to investigate whether tanshinone IIA inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cells via p53‑cyclin B1/cell division cycle gene 2 (CDC2). Cell proliferation, cytotoxicity and apoptosis of 13‑9B cells were evaluated by an MTT assay, lactate dehydrogenase assay and flow cytometry, respectively. ELISA and western blot analysis were used to analyze caspase‑3 activity and poly (ADP‑ribose) polymerase (PARP), p53, cyclin B1 and CDC2 protein expression in 13‑9B cells. Treatment of 13‑9B cells with tanshinone IIA significantly suppressed cell proliferation and significantly induced cytotoxicity and apoptosis of 13‑9B cells. Furthermore, tanshinone IIA significantly increased caspase‑3 activity, and significantly increased the protein expression levels of PARP, p53, cyclin B1 and CDC2 in 13‑9B cells. In summary, the current results indicate that tanshinone IIA inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cells via PARP, p53, cyclin B1/CDC2 and caspase‑3‑mediated signaling.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

Hui-Yuen JS, Li XQ and Askanase AD: Belimumab in systemic lupus erythematosus: A perspective review. Ther Adv Musculoskelet Dis. 7:115–121. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Ellis JS, Wan X and Braley-Mullen H: Transient depletion of CD4+ CD25+ regulatory T cells results in multiple autoimmune diseases in wild-type and B-cell-deficient NOD mice. Immunology. 139:179–186. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Venegas-Pont M, Manigrasso MB, Grifoni SC, LaMarca BB, Maric C, Racusen LC, Glover PH, Jones AV, Drummond HA and Ryan MJ: Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus. Hypertension. 56:643–649. 2010. View Article : Google Scholar : PubMed/NCBI

4 

Song B, Wang Z, Liu Y, Xu S, Huang G, Xiong Y, Zhang S, Xu L, Deng X and Guan S: Immunosuppressive activity of daphnetin, one of coumarin derivatives, is mediated through suppression of NF-κB and NFAT signaling pathways in mouse T cells. PLoS One. 9:e965022014. View Article : Google Scholar : PubMed/NCBI

5 

Yu WW, Lu Z, Zhang H, Kang YH, Mao Y, Wang HH, Ge WH and Shi LY: Anti-inflammatory and protective properties of daphnetin in endotoxin-induced lung injury. J Agric Food Chem. 62:12315–12325. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Shu K, Kuang N, Zhang Z, Hu Z, Zhang Y, Fu Y and Min W: Therapeutic effect of daphnetin on the autoimmune arthritis through demethylation of proapoptotic genes in synovial cells. J Transl Med. 12:2872014. View Article : Google Scholar : PubMed/NCBI

7 

Liao MJ, Lin LF, Zhou X, Zhou XW, Xu X, Cheng X, Gao Q and Luo HM: Daphnetin prevents chronic unpredictable stress-induced cognitive deficits. Fundam Clin Pharmacol. 27:510–516. 2013. View Article : Google Scholar : PubMed/NCBI

8 

Manhas A, Khanna V, Prakash P, Goyal D, Malasoni R, Naqvi A, Dwivedi AK, Dikshit M and Jagavelu K: Curcuma oil reduces endothelial cell-mediated inflammation in postmyocardial ischemia/reperfusion in rats. J Cardiovasc Pharmacol. 64:228–236. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Casella GT, Bunge MB and Wood PM: Improved immunocytochemical identification of neural, endothelial, and inflammatory cell types in paraffin-embedded injured adult rat spinal cord. J Neurosci Methods. 139:1–11. 2004. View Article : Google Scholar : PubMed/NCBI

10 

Yang EB, Zhao YN, Zhang K and Mack P: Daphnetin, one of coumarin derivatives, is a protein kinase inhibitor. Biochem Biophys Res Commun. 260:682–685. 1999. View Article : Google Scholar : PubMed/NCBI

11 

Liu L, Fu J, Li T, Cui R, Ling J, Yu X, Ji H and Zhang Y: NG, a novel PABA/NO-based oleanolic acid derivative, induces human hepatoma cell apoptosis via a ROS/MAPK-dependent mitochondrial pathway. Eur J Pharmacol. 691:61–68. 2012. View Article : Google Scholar : PubMed/NCBI

12 

Tessitore A, Cicciarelli G, Mastroiaco V, Del Vecchio F, Capece D, Verzella D, Fischietti M, Vecchiotti D, Zazzeroni F and Alesse E: Therapeutic Use of MicroRNAs in Cancer. Anticancer Agents Med Chem. 16:7–19. 2016. View Article : Google Scholar : PubMed/NCBI

13 

Liu J, Zheng L, Ma L, Wang B, Zhao Y, Wu N, Liu G and Lin X: Oleanolic acid inhibits proliferation and invasiveness of Kras-transformed cells via autophagy. J Nutr Biochem. 25:1154–1160. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Zhang HX, Wang ZT, Lu XX, Wang YG, Zhong J and Liu J: NLRP3 gene is associated with ulcerative colitis (UC), but not Crohn's disease (CD), in Chinese Han population. Inflamm Res. 63:979–985. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Cummings JR, Cooney RM, Clarke G, Beckly J, Geremia A, Pathan S, Hancock L, Guo C, Cardon LR and Jewell DP: The genetics of NOD-like receptors in Crohn's disease. Tissue Antigens. 76:48–56. 2010.PubMed/NCBI

16 

Villani AC, Lemire M, Fortin G, Louis E, Silverberg MS, Collette C, Baba N, Libioulle C, Belaiche J, Bitton A, et al: Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat Genet. 41:71–76. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Roberts RL, Topless RK, Phipps-Green AJ, Gearry RB, Barclay ML and Merriman TR: Evidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn's disease. Genes Immun. 11:351–356. 2010. View Article : Google Scholar : PubMed/NCBI

18 

Palejwala NV, Walia HS and Yeh S: Ocular manifestations of systemic lupus erythematosus: A review of the literature. Autoimmune Dis 2012. 2908982012.(Epub ahead of print). doi: 10.1155/2012/290898.

19 

Jolly CA, Muthukumar A, Reddy Avula CP and Fernandes G: Maintenance of NF-kappaB activation in T-lymphocytes and a naive T-cell population in autoimmune-prone (NZB/NZW)F(1) mice by feeding a food-restricted diet enriched with n-3 fatty acids. Cell Immunol. 213:122–133. 2001. View Article : Google Scholar : PubMed/NCBI

20 

Wong HK, Kammer GM, Dennis G and Tsokos GC: Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression. J Immunol. 163:1682–1689. 1999.PubMed/NCBI

21 

Liu J, Zheng L, Zhong J, Wu N, Liu G and Lin X: Oleanolic acid induces protective autophagy in cancer cells through the JNK and mTOR pathways. Oncol Rep. 32:567–572. 2014. View Article : Google Scholar : PubMed/NCBI

22 

Lu Y, Zhu M and Chen W, Yin L, Zhu J, Chen N and Chen W: Oleanolic acid induces apoptosis of MKN28 cells via AKT and JNK signaling pathways. Pharm Biol. 52:789–795. 2014. View Article : Google Scholar : PubMed/NCBI

23 

Ghasemlou N, Lopez-Vales R, Lachance C, Thuraisingam T, Gaestel M, Radzioch D and David S: Mitogen-activated protein kinase-activated protein kinase 2 (MK2) contributes to secondary damage after spinal cord injury. J Neurosci. 30:13750–13759. 2010. View Article : Google Scholar : PubMed/NCBI

24 

Li XQ, Cao XZ, Wang J, Fang B, Tan WF and Ma H: Sevoflurane preconditioning ameliorates neuronal deficits by inhibiting microglial MMP-9 expression after spinal cord ischemia/reperfusion in rats. Mol Brain. 7:692014. View Article : Google Scholar : PubMed/NCBI

25 

Chen J, Zhang X, Lentz C, Abi-Daoud M, Paré GC, Yang X, Feilotter HE and Tron VA: miR-193b Regulates Mcl-1 in Melanoma. Am J Pathol. 179:2162–2168. 2011. View Article : Google Scholar : PubMed/NCBI

26 

Munagala R, Aqil F, Jeyabalan J and Gupta RC: Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer. Cancer Lett 356 (2 Pt B). 536–546. 2015. View Article : Google Scholar

27 

Kaukoniemi KM, Rauhala HE, Scaravilli M, Latonen L, Annala M, Vessella RL, Nykter M, Tammela TL and Visakorpi T: Epigenetically altered miR-193b targets cyclin D1 in prostate cancer. Cancer Med. 4:1417–1425. 2015. View Article : Google Scholar : PubMed/NCBI

28 

Wahdan-Alaswad RS, Cochrane DR, Spoelstra NS, Howe EN, Edgerton SM, Anderson SM, Thor AD and Richer JK: Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b. Horm Cancer. 5:374–389. 2014. View Article : Google Scholar : PubMed/NCBI

29 

Blick C, Ramachandran A, McCormick R, Wigfield S, Cranston D, Catto J and Harris AL: Identification of a hypoxia-regulated miRNA signature in bladder cancer and a role for miR-145 in hypoxia-dependent apoptosis. Br J Cancer. 113:634–644. 2015. View Article : Google Scholar : PubMed/NCBI

30 

Zhang S, Guo Y, Zhang C, Gao W, Wen S, Huangfu H and Wang B: Primary laryngeal cancer-derived miR-193b induces interleukin-10-expression monocytes. Cancer Invest. 33:29–33. 2015. View Article : Google Scholar : PubMed/NCBI

31 

Su CC: Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression. Anticancer Res. 34:7097–7110. 2014.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Liu B, Liu L, Zang A, Song Z, Yang H, Wang Z, Shang Y, Ma T and Zhang Y: Tanshinone IIA inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cells via p53‑cyclin B1/CDC2. Oncol Lett 18: 3317-3322, 2019.
APA
Liu, B., Liu, L., Zang, A., Song, Z., Yang, H., Wang, Z. ... Zhang, Y. (2019). Tanshinone IIA inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cells via p53‑cyclin B1/CDC2. Oncology Letters, 18, 3317-3322. https://doi.org/10.3892/ol.2019.10658
MLA
Liu, B., Liu, L., Zang, A., Song, Z., Yang, H., Wang, Z., Shang, Y., Ma, T., Zhang, Y."Tanshinone IIA inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cells via p53‑cyclin B1/CDC2". Oncology Letters 18.3 (2019): 3317-3322.
Chicago
Liu, B., Liu, L., Zang, A., Song, Z., Yang, H., Wang, Z., Shang, Y., Ma, T., Zhang, Y."Tanshinone IIA inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cells via p53‑cyclin B1/CDC2". Oncology Letters 18, no. 3 (2019): 3317-3322. https://doi.org/10.3892/ol.2019.10658
Copy and paste a formatted citation
x
Spandidos Publications style
Liu B, Liu L, Zang A, Song Z, Yang H, Wang Z, Shang Y, Ma T and Zhang Y: Tanshinone IIA inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cells via p53‑cyclin B1/CDC2. Oncol Lett 18: 3317-3322, 2019.
APA
Liu, B., Liu, L., Zang, A., Song, Z., Yang, H., Wang, Z. ... Zhang, Y. (2019). Tanshinone IIA inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cells via p53‑cyclin B1/CDC2. Oncology Letters, 18, 3317-3322. https://doi.org/10.3892/ol.2019.10658
MLA
Liu, B., Liu, L., Zang, A., Song, Z., Yang, H., Wang, Z., Shang, Y., Ma, T., Zhang, Y."Tanshinone IIA inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cells via p53‑cyclin B1/CDC2". Oncology Letters 18.3 (2019): 3317-3322.
Chicago
Liu, B., Liu, L., Zang, A., Song, Z., Yang, H., Wang, Z., Shang, Y., Ma, T., Zhang, Y."Tanshinone IIA inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cells via p53‑cyclin B1/CDC2". Oncology Letters 18, no. 3 (2019): 3317-3322. https://doi.org/10.3892/ol.2019.10658
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team